153 related articles for article (PubMed ID: 31678385)
1. Cetuximab-conjugated chitosan-pectinate (modified) composite nanoparticles for targeting colon cancer.
Sabra R; Billa N; Roberts CJ
Int J Pharm; 2019 Dec; 572():118775. PubMed ID: 31678385
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic and anti-colon cancer properties of curcumin-containing chitosan-pectinate composite nanoparticles.
Alkhader E; Roberts CJ; Rosli R; Yuen KH; Seow EK; Lee YZ; Billa N
J Biomater Sci Polym Ed; 2018 Dec; 29(18):2281-2298. PubMed ID: 30376409
[TBL] [Abstract][Full Text] [Related]
3. Actively targeted cetuximab conjugated gamma-poly(glutamic acid)-docetaxel nanomedicines for epidermal growth factor receptor over expressing colon cancer cells.
Maya S; Sarmento B; Lakshmanan VK; Menon D; Jayakumar R
J Biomed Nanotechnol; 2014 Aug; 10(8):1416-28. PubMed ID: 25016642
[TBL] [Abstract][Full Text] [Related]
4. Cetuximab conjugated O-carboxymethyl chitosan nanoparticles for targeting EGFR overexpressing cancer cells.
Maya S; Kumar LG; Sarmento B; Sanoj Rejinold N; Menon D; Nair SV; Jayakumar R
Carbohydr Polym; 2013 Apr; 93(2):661-9. PubMed ID: 23499109
[TBL] [Abstract][Full Text] [Related]
5. Anticancer efficacy of 6-thioguanine loaded chitosan nanoparticles with or without curcumin.
Rajashekaraiah R; Kumar PR; Prakash N; Rao GS; Devi VR; Metta M; Narayanaswamy HD; Swamy MN; Satyanarayan K; Rao S; Rathnamma D; Sahadev A; Sunilchandra U; Santhosh CR; Dhanalakshmi H; Kumar SN; Ruban SW; Kalmath GP; Gomes AR; Kumar KRA; Govindappa PK
Int J Biol Macromol; 2020 Apr; 148():704-714. PubMed ID: 31954127
[TBL] [Abstract][Full Text] [Related]
6. Curcumin-loaded polymeric nanoparticles for enhanced anti-colorectal cancer applications.
Udompornmongkol P; Chiang BH
J Biomater Appl; 2015 Nov; 30(5):537-46. PubMed ID: 26170212
[TBL] [Abstract][Full Text] [Related]
7. Chitosan/alginate nanoparticles as a promising approach for oral delivery of curcumin diglutaric acid for cancer treatment.
Sorasitthiyanukarn FN; Muangnoi C; Ratnatilaka Na Bhuket P; Rojsitthisak P; Rojsitthisak P
Mater Sci Eng C Mater Biol Appl; 2018 Dec; 93():178-190. PubMed ID: 30274050
[TBL] [Abstract][Full Text] [Related]
8. Chitosan-based nano-in-microparticle carriers for enhanced oral delivery and anticancer activity of propolis.
Elbaz NM; Khalil IA; Abd-Rabou AA; El-Sherbiny IM
Int J Biol Macromol; 2016 Nov; 92():254-269. PubMed ID: 27397719
[TBL] [Abstract][Full Text] [Related]
9. Chitosan nanoparticles for lipophilic anticancer drug delivery: Development, characterization and in vitro studies on HT29 cancer cells.
Abruzzo A; Zuccheri G; Belluti F; Provenzano S; Verardi L; Bigucci F; Cerchiara T; Luppi B; Calonghi N
Colloids Surf B Biointerfaces; 2016 Sep; 145():362-372. PubMed ID: 27214786
[TBL] [Abstract][Full Text] [Related]
10. Mucoadhesive Chitosan-Pectinate Nanoparticles for the Delivery of Curcumin to the Colon.
Alkhader E; Billa N; Roberts CJ
AAPS PharmSciTech; 2017 May; 18(4):1009-1018. PubMed ID: 27582072
[TBL] [Abstract][Full Text] [Related]
11. EGFR-targeted hybrid lipid nanoparticles for chemo-photothermal therapy against colorectal cancer cells.
Fang F; Zhang X; Tang J; Wang Y; Xu J; Sun Y
Chem Phys Lipids; 2023 Mar; 251():105280. PubMed ID: 36634728
[TBL] [Abstract][Full Text] [Related]
12. In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies.
Anitha A; Sreeranganathan M; Chennazhi KP; Lakshmanan VK; Jayakumar R
Eur J Pharm Biopharm; 2014 Sep; 88(1):238-51. PubMed ID: 24815764
[TBL] [Abstract][Full Text] [Related]
13. Characterization and anti-proliferative activity of curcumin loaded chitosan nanoparticles in cervical cancer.
Khan MA; Zafaryab M; Mehdi SH; Ahmad I; Rizvi MM
Int J Biol Macromol; 2016 Dec; 93(Pt A):242-253. PubMed ID: 27565296
[TBL] [Abstract][Full Text] [Related]
14. Cellular uptake and anticancer effects of mucoadhesive curcumin-containing chitosan nanoparticles.
Chuah LH; Roberts CJ; Billa N; Abdullah S; Rosli R
Colloids Surf B Biointerfaces; 2014 Apr; 116():228-36. PubMed ID: 24486834
[TBL] [Abstract][Full Text] [Related]
15. Cetuximab-conjugated iron oxide nanoparticles for cancer imaging and therapy.
Tseng SH; Chou MY; Chu IM
Int J Nanomedicine; 2015; 10():3663-85. PubMed ID: 26056447
[TBL] [Abstract][Full Text] [Related]
16. Electrostatic Self-Assembled Chitosan-Pectin Nano- and Microparticles for Insulin Delivery.
Maciel VBV; Yoshida CMP; Pereira SMSS; Goycoolea FM; Franco TT
Molecules; 2017 Oct; 22(10):. PubMed ID: 29023400
[TBL] [Abstract][Full Text] [Related]
17. Efficient Colonic Delivery of DsiRNA by Pectin-Coated Polyelectrolyte Complex Nanoparticles: Preparation, Characterization and Improved Gastric Survivability.
Hussain Z; Katas H; Yan SL; Jamaludin D
Curr Drug Deliv; 2017; 14(7):1016-1027. PubMed ID: 28240178
[TBL] [Abstract][Full Text] [Related]
18. A Chimeric Cetuximab-Functionalized Corona as a Potent Delivery System for Microtubule-Destabilizing Nanocomplexes to Hepatocellular Carcinoma Cells: A Focus on EGFR and Tubulin Intracellular Dynamics.
Poojari R; Kini S; Srivastava R; Panda D
Mol Pharm; 2015 Nov; 12(11):3908-23. PubMed ID: 26426829
[TBL] [Abstract][Full Text] [Related]
19. Optimally designed theranostic system based folic acids and chitosan as a promising mucoadhesive delivery system for encapsulating curcumin LbL nano-template against invasiveness of breast cancer.
Hanafy NAN
Int J Biol Macromol; 2021 Jul; 182():1981-1993. PubMed ID: 34058209
[TBL] [Abstract][Full Text] [Related]
20. Cetuximab conjugated and doxorubicin loaded silica nanoparticles for tumor-targeting and tumor microenvironment responsive binary drug delivery of liver cancer therapy.
Wang JK; Zhou YY; Guo SJ; Wang YY; Nie CJ; Wang HL; Wang JL; Zhao Y; Li XY; Chen XJ
Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():944-950. PubMed ID: 28482611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
